Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.
Puthenparampil M, Gaggiola M, Miscioscia A, Mauceri VA, De Napoli F, Zanotelli G, Anglani M, Nosadini M, Sartori S, Perini P, Rinaldi F, Gallo P.
Puthenparampil M, et al. Among authors: miscioscia a.
Ther Adv Neurol Disord. 2023 Oct 6;16:17562864231177196. doi: 10.1177/17562864231177196. eCollection 2023.
Ther Adv Neurol Disord. 2023.
PMID: 37808246
Free PMC article.